You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

March 2003

Volume 55, Issue 3

Pages 223–326

  1. Editor's View

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Features of this month's Journal (pages 223–224)

      J. K. Aronson

      Article first published online: 16 MAY 2007 | DOI: 10.1111/j.1365-2125.2003.1830a.x

  2. Editorial

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
  3. Review Article

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
  4. Clinical Toxicology

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol (pages 234–240)

      Eran Kozer, Sandra Evans, Joseph Barr, Revital Greenberg, Ingrid Soriano, Mordechai Bulkowstein, Irena Petrov, Zehava Chen-Levi, Bernard Barzilay and Matitiahu Berkovitch

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01723.x

  5. Pharmacokinetics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
  6. Pharmacodynamics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization (pages 246–251)

      Robert T. C. E. Robinson, Nigel D. Harris, Robert H. Ireland, Anders Lindholm and Simon R. Heller

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01726.x

  7. Pharmacokinetics/Pharmacodynamics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Population pharmacokinetics and concentration–effect relationships of capecitabine metabolites in colorectal cancer patients (pages 252–263)

      Ronald Gieschke, Hans-Ulrich Burger, Bruno Reigner, Karen S. Blesch and Jean-Louis Steimer

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01765.x

  8. Drug Disposition

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      The distribution and gender difference of CYP3A activity in Chinese subjects (pages 264–269)

      Bing Zhu, Zhao-Qian Liu, Guo-Lin Chen, Xiao-Ping Chen, Dong-Sheng Ou-Yang, Lian-Sheng Wang, Song-Lin Huang, Zhi-Rong Tan and Hong-Hao Zhou

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01728.x

    2. You have free access to this content
      Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients (pages 270–277)

      How Sung Lee, Boon Cher Goh, Lu Fan, Yok Moi Khoo, Lingzhi Wang, Robert Lim, Ai Bee Ong and Charlotte Chua

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01767.x

  9. Pharmacogenetics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Arylamine N-acetyltransferase-2 genotypes in the Thai population (pages 278–281)

      Veerapol Kukongviriyapan, Auemduan Prawan, Wichittra Tassaneyakul, Jareerat Aiemsa-ard and Benjamart Warasiha

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01766.x

  10. Therapeutics

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
    2. You have free access to this content
  11. Clinical Trial Design

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods (pages 299–306)

      Jean-Sébastien Hulot, Michel Cucherat, Andrew Charlesworth, Dirk J. Van Veldhuisen, Jean-Christophe Corvol, Alain Mallet, Jean-Pierre Boissel, John Hampton and Philippe Lechat

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01768.x

  12. Short Reports

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
    2. You have free access to this content
      Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis (pages 310–313)

      Daniel K. C. Lee, Fiona M. Robb, Erika J. Sims, Graeme P. Currie, Lesley C. McFarlane and Brian J. Lipworth

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01729.x

    3. You have free access to this content
    4. You have free access to this content
      Development, implementation and cost-effectiveness of a protocol for review of combination diuretic prescribing (pages 317–320)

      Julie D. Morgan, David J. Wright, Henry Chrystyn, Bethan George, Andrew C. Booth and David J. Shoesmith

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01784.x

    5. You have free access to this content
      Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population (pages 321–324)

      Samar I. Hamdy, Masahiro Hiratsuka, Kaori Narahara, Naomi Endo, Mervat El-Enany, Nadia Moursi, Mohammed S.-E. Ahmed and Michinao Mizugaki

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01787.x

  13. Letters to the Editors

    1. Top of page
    2. Editor's View
    3. Editorial
    4. Review Article
    5. Clinical Toxicology
    6. Pharmacokinetics
    7. Pharmacodynamics
    8. Pharmacokinetics/Pharmacodynamics
    9. Drug Disposition
    10. Pharmacogenetics
    11. Therapeutics
    12. Clinical Trial Design
    13. Short Reports
    14. Letters to the Editors
    1. You have free access to this content
      Concomitant overdosing of other drugs in patients with paracetamol poisoning (page 325)

      Geoffrey K. Isbister, Ian M. Whyte, Fiona Downes, Andrew H. Dawson and Patricia McGettigan

      Article first published online: 10 MAR 2003 | DOI: 10.1046/j.1365-2125.2003.01761.x

    2. You have free access to this content
      Concomitant overdosing of other drugs in patients with paracetamol poisoning (page 326)

      Lars E. Schmidt and Kim Dalhoff

      Article first published online: 2 MAY 2002 | DOI: 10.1046/j.0306-5251.2001.01508.x-i1

SEARCH

SEARCH BY CITATION